| PHARMASURGICS IN SWEDEN AB Patent applications |
| Patent application number | Title | Published |
|---|
| 20110224152 | SYNTHETIC ARGININE SUBSTITUTED PEPTIDES AND THEIR USE - The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars. | 09-15-2011 |
| 20100305048 | NOVEL USE OF CYTOKINE INHIBITORS - The use of substance that inhibits a pro-inflammatory cytokine, such as TNF or IL-1, for the production of a pharmaceutical composition for improving wound healing is disclosed. Also, a method for improving wound healing wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine is administered to a patient in need of said treatment is disclosed. | 12-02-2010 |
| 20090186823 | Synthetic arginine substituted peptides and their use - The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars. | 07-23-2009 |
| 20090149379 | NOVEL USE OF CYTOKINE INHIBITORS - The present invention relates to a method for prevention or reduction of scar tissue and/or adhesion formation wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine is administered to a patient in need of said treatment. | 06-11-2009 |
| 20080299180 | Peptides based on the sequence of human lactoferrin and their use - The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides. | 12-04-2008 |
